Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6−/−) mice
- 31 December 2000
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (6), 967-974
- https://doi.org/10.1016/s0168-8278(00)80130-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomasOncogene, 1999
- Mitosis and Apoptosis in the Liver of Interleukin–6-Deficient Mice After Partial HepatectomyHepatology, 1999
- Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and SteatosisJournal of Biological Chemistry, 1998
- Changes in expression of CCAAT/enhancer binding protein α (C/EBPα) and C/EBPβ in rat liver after partial hepatectomy but not after treatment with cyproterone acetateJournal of Hepatology, 1997
- Liver RegenerationScience, 1997
- Fulminant Hepatic Failure in Rats: Survival and Effect on Blood Chemistry and Liver RegenerationHepatology, 1996
- Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient MiceScience, 1996
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomyJournal of Endocrinology, 1992
- In vivo studies on the antiandrogenic effects of cimetidine versus cyproterone acetate in ratsThe Prostate, 1981